NovaBay Pharmaceuticals Changes Name to Stablecoin Development Corporation

lunes, 23 de marzo de 2026, 11:46 am ET1 min de lectura
NBY--

NovaBay Pharmaceuticals has changed its name to Stablecoin Development Corporation, shifting focus from wound care products to stablecoin development. The company previously manufactured and sold its proprietary form of hypochlorous acid for wound care through its NeutroPhase and PhaseOne branded products. The name change reflects the company's new direction in stablecoin development.

NovaBay Pharmaceuticals Changes Name to Stablecoin Development Corporation

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios